Language selection

Government of Canada

Search

Details for: PRIVA-PRAVASTATIN

Company: PHARMAPAR INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02445379PRIVA-PRAVASTATINPRAVASTATIN SODIUM10 MGTABLETORAL
02445395PRIVA-PRAVASTATINPRAVASTATIN SODIUM20 MGTABLETORAL
02445409PRIVA-PRAVASTATINPRAVASTATIN SODIUM40 MGTABLETORAL
Search Reported Side Effects Report a Side Effect

Consumer Information

This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.

What the medication is used for

Priva-PRAVASTATIN is available only with your physician's prescription. It is to be used as an adjunct to a medically recommended and carefully supervised diet for the long -term treatment of hypercholesterolemia and is not a substitute for such a diet. This has been shown to decrease the chances of experiencing a first or second heart attack, or stroke, and may help prevent heart disease if caused by cholesterol clogging the blood vessels, or slow the progression of atherosclerosis (hardening) of the arteries that nourish your heart, so-called coronary heart disease (CHD). In addition, depending on your condition, your physician may recommend an appropriate regimen of exercise, weight control and other measures.

What it does

Priva-PRAVASTATIN lowers the level of cholesterol, particularly Low Density Lipoprotein (LDL) cholesterol, in the blood. Priva-PRAVASTATIN reduces cholesterol production by the liver and induces some changes of cholesterol transport and disposition in the blood and tissues.

When it should not be used

If you are pregnant, since its use in the event of pregnancy may harm the unborn. Only female patients who are highly unlikely to conceive can be candidates for Priva-PRAVASTATIN treatment. In the event of pregnancy during treatment, Priva-PRAVASTATIN should be discontinued and the physician should be informed.

  • If you know that you are allergic to pravastatin or any of the non-medicinal ingredients of Priva-PRAVASTATIN.
  • If you have liver disease.
  • In adolescents and children since the safety of Priva-PRAVASTATIN in this age group has not been established.
What the medicinal ingredient is

pravastatin sodium

What the non-medicinal ingredients are

Anhydrous lactose, magnesium oxide, croscarmellose sodium, microcrystalline cellulose, povidone, crospovidone and magnesium stearate.

Along with the above non-medicinal ingredients tablets have colouring agents too: Ferric oxide red in 10 mg, Ferric oxide yellow in 20 mg and FD& C blue No. 1 Al. Lake & D& C yellow No. 10 Al. Lake in 40 mg tablet

What dosage form it comes in

10 mg, 20 mg and 40 mg tablets.

Warnings and precautions

Use only as specifically directed. Do not alter the dosage unless ordered to do so by your physician. Check with your physician before discontinuing medication since this may result in an increase of your blood lipids.

Before taking Priva-PRAVASTATIN, tell your doctor or pharmacist if you:

  • are breast-feeding or intend to breast-feed,
  • have thyroid problems,
  • have a family history of muscular disorders,
  • had any past problems with the muscles (pain, tenderness), after using an HMG-CoA reductase inhibitor ("statin") such as atorvastatin (Lipitor®)1 fluvastatin (Lescol®)2, lovastatin (Mevacor®)3, pravastatin (Pravachol®)5, rosuvastatin (Crestor®)4 or simvastatin (Zocor®)3, or have developed an allergy or intolerance to them,
  • have kidney or liver problems,
  • diabetes,
  • have undergone surgery or other tissue injury,
  • do excessive physical exercise.
1 Lipitor® is a registered trademark of Pfizer Ireland Pharmaceuticals.
2 Lescol® is a registered trademark of Sandoz Canada Inc.
3 Mevacor® and Zocor® are registered trademarks of Merck & Co., Inc.
4 Crestor® is a registered trademark of IPR Pharmaceuticals Inc.
5 Pravachol® is a registered trademark of Bristol-Meyers Squibb Company.
Pregnancy
Before using this medication, discuss the following with your doctor:
  • Cholesterol compounds are essential elements for the development of a fetus.
  • Cholesterol-lowering drugs can harm the fetus. If you are of child-bearing age, discuss with your doctor the potential hazards to the fetus and the importance of birth control methods.
  • Priva-PRAVASTATIN should not be used by pregnant women. If you become pregnant, discontinue use immediately and discuss with your doctor.
Slightly increased blood sugar can occur when you take HMG-CoA reductase inhibitor (“statin”). Discuss with the doctor your risk of developing diabetes
Interactions with this medication

Priva-PRAVASTATIN may interact with other drugs, including those you take without a prescription. You must tell your doctor or pharmacist about all drugs, including prescription and non-prescription, herbal products and supplements, you are taking or planning to take before you take Priva-PRAVASTATIN.

You should tell your doctor if you are taking other cholesterol lowering medication such as fibrates (gemfibrozil, fenofibrate), niacin, or ezetimibe. If you take these drugs and Priva-PRAVASTATIN together, you may be at an increased risk of myopathy (muscle disease with aching or weakness).

If you are taking a bile acid -binding resin (such as cholestyramine, colestipol), your doctor will recommend that you take Priva-PRAVASTATIN either one hour or more before or at least four hours following the resin. Taking them together causes lower amounts of Priva-PRAVASTATIN in the blood, making it less effective.

If you are taking cyclosporine, your doctor may need to adjust the dose of Priva-PRAVASTATIN.

Excessive alcohol intake should be avoided when taking Priva-PRAVASTATIN. Tell your doctor if you regularly drink three or more alcoholic drinks daily

Proper use of this medication

  • Do not change the dose unless directed by a doctor.
  • Priva-PRAVASTATIN should be taken as a single dose at bedtime, as prescribed by your physician.
  • Your physician will monitor your clinical condition and your blood tests at regular intervals. It is important to have these check-ups done on schedule. Please keep your appointments accurately.
  • Notify your physician about any illness which may develop during your treatment with Priva-PRAVASTATIN and about any new prescription or non-prescription medication you may take. If you require medical help for other reasons, inform the attending physician that you are taking Priva-PRAVASTATIN,
  • Notify your physician if you are going to have major surgery or have sustained a severe injury,
  • Notify your physician of any muscle pain, tenderness or weakness developing during treatment with Priva-PRAVASTATIN (see SIDE EFFECTS AND WHAT TO DO ABOUT THEM).

Usual Dose

The recommended starting dose is 20 mg once daily at bed time. Patients who require a large dose reduction in LDL-C may be started at 40 mg once daily. The dose of 80 mg once daily should be reserved for patients who do not achieve their treatment goal with lower doses. Priva-PRAVASTATIN may be taken without regard to meals.

Overdose

There is no specific recommended therapy for overdose with Priva-PRAVASTATIN.

For management of a suspected drug overdose, contact your health care practitioner, hospital emergency department, or regional Poison Control center immediately.
Side effects and what to do about them

Along with its intended action, any medication may cause unwanted effects.

Check with your physician as soon as possible if any of the following side effects occurs: aching muscles muscle cramping, tiredness or weakness, fever and blurred vision.

Muscle effects

Side effects such as myalgia (muscle pain), myopathy (muscle disease with aching or weakness), rhabdomyolosis (a muscle wasting disease), associated tenderness, and rare cases of rhabdomylosis leading to kidney failure have been reported with other drugs of this class, known as HMG-CoA reductase inhibitors ("statins"), including Priva-PRAVASTATIN.

As these muscle problems are on rare occasions serious, you should contact your physician promptly if you experience any of the side effects listed in the Table below.

Possible side effects reported with some statins: breathing problems including persistent cough and/or shortness of breath or fever, mood problems including depression, problems sleeping including insomnia and nightmares and sexual problems.

Poor memory, confusion and memory loss have also been reported with all statins.

Priva-PRAVASTATIN can also cause abnormal blood test results. Your doctor will decide when to perform blood tests and will interpret the results.

Serious side effects, how often they happen and what to do about them
Symptom / effect Talk with your doctor or pharmacist only if severe Talk with your docto or pharmacist in all cases Stop taking drug and seek immediate emergency medical attention
Rare
Muscle pain that you cannot explain   ✔  
Muscle tenderness or muscle weakness   ✔  
Generalized weakness, especially if you do not feel well (i.e. fever or fatigue)   ✔  
Brownish or discoloured urine   ✔  
Symptoms of liver problems (upper belly pain, dark urine, itchy skin, nausea or vomiting, loss of appetite, pale stools, yellowing of skin or the whites of your eyes     ✔
Unknown
Increased blood sugar: frequent urination, thirst and hunger ✔    

Other side effects may occasionally occur which usually do not require stopping treatment. They may come and go during treatment without any particular danger, but you should mention them to your physician, without undue delay, if they become persistent or bothersome. Such adverse experiences include abdominal pain, constipation, diarrhea, nausea, headache, dizziness and skin rashes.

This is not a complete list of side effects. For any unexpected effects while taking Priva-PRAVASTATIN, contact your doctor or pharmacist.

How to store

Priva-PRAVASTATIN should be stored at room temperature (15-30°C). Protect from moisture and light.

Reporting side effects

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance

Program by one of the following 3 ways:
Report online at www.healthcanada.gc.ca/medeffect
Call toll-free at 1-866-234-2345
Complete a Canada Vigilance Reporting Form and:

  • Fax toll-free to 1-866-678-6789, or
  • Mail to: Canada Vigilance Program
    Health Canada
    Postal Locator 0701E
    Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

More information

This document plus the full product monograph, prepared for health professionals can be found by contacting Pharmapar Inc.

This leaflet was prepared by:
Pharmapar Inc.
100-5950, Ch. de la Côte de Liesse
Mont-Royal, Qc, H4T 1E2

Phone# (514) 731-2003; Fax: (514) 731-2004

Date of Preparation: September 1, 2015

Date modified: